Samuel N. Helman

Mount Sinai Health System

Papers

1

Total Citations

16

H-Index

1

About

Dr. Samuel N. Helman is a leading head and neck surgeon whose research centers on minimally invasive surgical techniques, particularly transoral robotic surgery (TORS), and their application in oropharyngeal carcinoma. His most-cited work, a 2015 study on TORS in oropharyngeal cancer, has garnered 16 citations and is foundational in understanding how robotic approaches are reshaping treatment paradigms. Dr. Helman’s contributions are especially significant given the dramatic shift in oropharyngeal cancer etiology—from tobacco and alcohol to human papillomavirus (HPV)—which has improved patient survival but also demands more precise, function-preserving interventions. By demonstrating the efficacy of TORS in this evolving landscape, his research helps guide clinicians toward less morbid surgical options that maintain oncologic outcomes. Beyond this landmark paper, Dr. Helman has advanced the field through studies on surgical outcomes, patient quality of life, and the integration of robotics into multidisciplinary care. His work has been instrumental in establishing TORS as a standard approach for select oropharyngeal cancers, directly impacting treatment guidelines and patient recovery. For students and researchers, Dr. Helman’s career exemplifies how surgical innovation can adapt to changing disease biology, offering a model for translating epidemiological shifts into improved clinical practice.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Transoral Robotic Surgery in Oropharyngeal Carcinoma
16 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Mount Sinai Health System

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago